CIBLOR Side Effects

6461112-4 | Anaphylactoid Shock, Blood Pressure Decreased
on Nov 18, 2009 Female patient from FRANCE , 31 years of age, was diagnosed with oral infection and was treated with Ciblor (View Usage). Patient experienced the following unwanted or unexpected effects: anaphylactoid shock, blood pressure decreased. Ciblor dosage: 1z Single Dose.

6101754-9 | Anaemia, Anaemia Haemolytic Autoimmune, Anti-erythropoietin Antibody, Chest Pain, Conjunctival Discolouration, Dyspnoea, Dyspnoea Exertional, Gait Disturbance, Haemoglobin Abnormal
Patient was taking Ciblor (View Usage). Patient had the following side effects: anaemia, anaemia haemolytic autoimmune, anti-erythropoietin antibody, chest pain (What is chest pain?), conjunctival discolouration, dyspnoea, dyspnoea exertional, gait disturbance, haemoglobin abnormal on Feb 27, 2009 from FRANCE Additional patient health information: Male patient , 62 years of age, . Ciblor dosage: 3g Per Day. During the same period patient was treated with VASTAREL (70mg Per Day) (View Vastarel Review and Vastarel Label ), SOLUPRED (View Solupred Review and Solupred Label ), SYMBICORT (View Symbicort Review and Symbicort Label ), MUCOMYST (View Mucomyst Review and Mucomyst Label ). Patient was hospitalized.

5712883-3 | Confusional State, Urinary Retention
Adverse event was reported on Apr 18, 2008 by a Female patient taking Ciblor (View Usage) (Dosage: ) was diagnosed with bronchitis (What is bronchitis?) and. Location: FRANCE , 92 years of age, After Ciblor was administered, patient had the following side effects: confusional state, urinary retention. During the same period patient was treated with PROZAC (View Prozac Review and Prozac Label ). Patient was hospitalized.

5696094-6 | Angioedema, Pruritus
on Apr 03, 2008 Male patient from FRANCE , 30 years of age, was diagnosed with nasopharyngitis and was treated with Ciblor (View Usage). Patient experienced the following unwanted or unexpected effects: angioedema, pruritus. Ciblor dosage: . During the same period patient was treated with DI ANTALVIC (View Di Antalvic Review and Di Antalvic Label ), ASPEGIC 1000 (View Aspegic 1000 Review and Aspegic 1000 Label ), PREDNISONE (View Prednisone Review and Prednisone Label ). Patient was hospitalized.


5600141-7 | Dysphagia, Dysuria, Genital Ulceration, Gingival Ulceration, Hyperthermia, Mouth Ulceration, Mucocutaneous Rash, Penile Ulceration, Prurigo
on Jan 18, 2008 Male patient from FRANCE , 70 years of age, was treated with Ciblor (View Usage). Patient had the following side effects: dysphagia, dysuria, genital ulceration, gingival ulceration, hyperthermia, mouth ulceration, mucocutaneous rash, penile ulceration, prurigo. Ciblor dosage: 1sac Per Day. During the same period patient was treated with TAMSULOSIN HCL (View Tamsulosin Hcl Review and Tamsulosin Hcl Label ). Patient was hospitalized.

5597603-8 | Cutaneous Vasculitis, Lung Disorder, Pyrexia
Patient was taking Ciblor (View Usage). After Ciblor was administered, patient had the following side effects: cutaneous vasculitis, lung disorder, pyrexia on Jan 14, 2008 from FRANCE Additional patient health information: Male patient , 77 years of age, was diagnosed with bronchial disorder, arrhythmia (What is arrhythmia?) and. Ciblor dosage: . During the same period patient was treated with BISOPROLOL FUMARATE (5mg Per Day) (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), CORTANCYL (60mg Per Day) (View Cortancyl Review and Cortancyl Label ), DERINOX (View Derinox Review and Derinox Label ), POLERY (2sp Three Times Per Day) (View Polery Review and Polery Label ), BETNEVAL (1app Twice Per Day) (View Betneval Review and Betneval Label ), LERCAN (View Lercan Review and Lercan Label ), PRAVASTATIN (View Pravastatin Review and Pravastatin Label ), AMIODARONE (200mg Per Day) (View Amiodarone Review and Amiodarone Label ). Patient was hospitalized.

5579215-5 | Blood Pressure, Cutaneous Vasculitis, Entropion, Lung Disorder, Mouth Ulceration, Purpura, Pyrexia
Adverse event was reported on Dec 26, 2007 by a Male patient taking Ciblor (View Usage) (Dosage: ) was diagnosed with bronchial disorder and. Location: FRANCE , 77 years of age, Patient experienced the following unwanted or unexpected effects: blood pressure (What is blood pressure?), cutaneous vasculitis, entropion, lung disorder, mouth ulceration, purpura, pyrexia. During the same period patient was treated with BISOPROLOL (5mg Per Day) (View Bisoprolol Review and Bisoprolol Label ), CORTANCYL (30mg Three Times Per Day) (View Cortancyl Review and Cortancyl Label ), POLERY (View Polery Review and Polery Label ), BETNEVAL (View Betneval Review and Betneval Label ), LERCAN (View Lercan Review and Lercan Label ), PRAVASTATIN (View Pravastatin Review and Pravastatin Label ), AMIODARONE HCL (View Amiodarone Hcl Review and Amiodarone Hcl Label ), PLAVIX (View Plavix Review and Plavix Label ). Patient was hospitalized.

5263839-9 | Aphthous Stomatitis, Duodenal Ulcer, Faeces Discoloured, Haematemesis, Pyrexia, Rash Erythematous
on Mar 02, 2007 Male patient from FRANCE , weighting 21.61 lb, was diagnosed with tonsillitis and was treated with Ciblor (View Usage). Patient had the following side effects: aphthous stomatitis, duodenal ulcer, faeces discoloured, haematemesis, pyrexia, rash erythematous. Ciblor dosage: . During the same period patient was treated with CELESTENE (1.25mgd Per Day) (View Celestene Review and Celestene Label ). Patient was hospitalized.

5193768-0 | Candida Sepsis, Cardiac Failure, Clostridium Difficile Colitis, Confusional State, Culture Positive, Culture Stool Positive, Culture Urine Positive, Cytomegalovirus Antibody Positive
on Dec 11, 2006 Female patient from FRANCE , 64 years of age, was diagnosed with bronchopneumopathy and was treated with Ciblor (View Usage). After Ciblor was administered, patient had the following side effects: candida sepsis, cardiac failure, clostridium difficile colitis, confusional state, culture positive, culture stool positive, culture urine positive, cytomegalovirus antibody positive. Ciblor dosage: 1g Three Times Per Day. During the same period patient was treated with SEGLOR (View Seglor Review and Seglor Label ), ALLOPURINOL SODIUM (View Allopurinol Sodium Review and Allopurinol Sodium Label ), PAROXETINE HCL (View Paroxetine Hcl Review and Paroxetine Hcl Label ), DIAMICRON (View Diamicron Review and Diamicron Label ), DEPAMIDE (View Depamide Review and Depamide Label ), TAHOR (View Tahor Review and Tahor Label ), NOCTRAN (View Noctran Review and Noctran Label ), ALPRAZOLAM (View Alprazolam Review and Alprazolam Label ). Patient was hospitalized.

5041226-6 | Cerebral Haemorrhage, Coma, Eosinophilia, Nonspecific Reaction, Oral Soft Tissue Disorder, Prothrombin Level Decreased
Patient was taking Ciblor (View Usage). Patient experienced the following unwanted or unexpected effects: cerebral haemorrhage, coma, eosinophilia, nonspecific reaction, oral soft tissue disorder, prothrombin level decreased on Jun 20, 2006 from FRANCE Additional patient health information: Male patient , 51 years of age, was diagnosed with orchitis, phlebitis and. Ciblor dosage: . During the same period patient was treated with LAMICTAL (View Lamictal Review and Lamictal Label ), CIFLOX (View Ciflox Review and Ciflox Label ), PREVISCAN (10mg Per Day) (View Previscan Review and Previscan Label ). Patient was hospitalized.

5041220-5 | Cerebral Haemorrhage, Coma, Prothrombin Level Decreased, Purpura, Pyrexia, Rash Maculo-papular, Shock, Toxic Skin Eruption
Adverse event was reported on Jun 07, 2006 by a Male patient taking Ciblor (View Usage) (Dosage: ) was diagnosed with orchitis, phlebitis and. Location: FRANCE , 51 years of age, Patient had the following side effects: cerebral haemorrhage, coma, prothrombin level decreased, purpura, pyrexia, rash maculo-papular, shock, toxic skin eruption. During the same period patient was treated with LAMICTAL (View Lamictal Review and Lamictal Label ), CIFLOX (View Ciflox Review and Ciflox Label ), PREVISCAN (10mg At Night) (View Previscan Review and Previscan Label ). Patient was hospitalized.

5037581-3 | Cerebral Haemorrhage, Coma, Eosinophilia, Nonspecific Reaction, Oral Soft Tissue Disorder, Prothrombin Level Decreased
on Jun 20, 2006 Male patient from FRANCE , 51 years of age, was diagnosed with orchitis, phlebitis and was treated with Ciblor (View Usage). After Ciblor was administered, patient had the following side effects: cerebral haemorrhage, coma, eosinophilia, nonspecific reaction, oral soft tissue disorder, prothrombin level decreased. Ciblor dosage: . During the same period patient was treated with LAMICTAL (View Lamictal Review and Lamictal Label ), CIFLOX (View Ciflox Review and Ciflox Label ), PREVISCAN (10mg Per Day) (View Previscan Review and Previscan Label ). Patient was hospitalized.

5028481-3 | Cerebral Haemorrhage, Coma, Prothrombin Level Decreased, Purpura, Pyrexia, Rash Maculo-papular, Shock, Toxic Skin Eruption
on Jun 07, 2006 Male patient from FRANCE , 51 years of age, was diagnosed with orchitis, phlebitis and was treated with Ciblor (View Usage). Patient experienced the following unwanted or unexpected effects: cerebral haemorrhage, coma, prothrombin level decreased, purpura, pyrexia, rash maculo-papular, shock, toxic skin eruption. Ciblor dosage: . During the same period patient was treated with LAMICTAL (View Lamictal Review and Lamictal Label ), CIFLOX (View Ciflox Review and Ciflox Label ), PREVISCAN (10mg At Night) (View Previscan Review and Previscan Label ). Patient was hospitalized.

4998458-2 | Eczema, Oedema Peripheral, Pitting Oedema, Prurigo, Pyrexia, Rash Erythematous, Rash Papular, Skin Exfoliation
Patient was taking Ciblor (View Usage). Patient had the following side effects: eczema (What is eczema?), oedema peripheral, pitting oedema, prurigo, pyrexia, rash erythematous, rash papular, skin exfoliation on Apr 28, 2006 from FRANCE Additional patient health information: Male patient , 40 years of age, . Ciblor dosage: 3g Per Day. During the same period patient was treated with HEXOMEDINE (View Hexomedine Review and Hexomedine Label ), FRAGMIN (View Fragmin Review and Fragmin Label ). Patient was hospitalized.

4918971-3 | Anaphylactoid Reaction, Dysphonia, Dyspnoea, Eyelid Oedema, Oedema Peripheral, Urticaria
Adverse event was reported on Feb 16, 2006 by a Female patient taking Ciblor (View Usage) (Dosage: 1tab Per Day) . Location: FRANCE , 27 years of age, After Ciblor was administered, patient had the following side effects: anaphylactoid reaction, dysphonia, dyspnoea, eyelid oedema, oedema peripheral, urticaria. During the same period patient was treated with DOLIPRANE (View Doliprane Review and Doliprane Label ), BRONCHOKOD (View Bronchokod Review and Bronchokod Label ). Patient was hospitalized.

4917400-3 | Malaise, Orthostatic Hypotension
on Feb 16, 2006 Male patient from FRANCE , 64 years of age, was diagnosed with bronchitis (What is bronchitis?) and was treated with Ciblor (View Usage). Patient experienced the following unwanted or unexpected effects: malaise, orthostatic hypotension. Ciblor dosage: 3g Per Day. Patient was hospitalized.

4886169-3 | International Normalised Ratio Increased
on Jan 03, 2006 Male patient from FRANCE , 76 years of age, was treated with Ciblor (View Usage). Patient had the following side effects: international normalised ratio increased. Ciblor dosage: 1g Twice Per Day. During the same period patient was treated with COUMADIN (2mg Per Day) (View Coumadin Review and Coumadin Label ), KETEK (400mg Twice Per Day) (View Ketek Review and Ketek Label ), CALCIPARINE (.2ml Twice Per Day) (View Calciparine Review and Calciparine Label ), TAVANIC (View Tavanic Review and Tavanic Label ). Patient was hospitalized.

4873155-2 | International Normalised Ratio Increased
Patient was taking Ciblor (View Usage). After Ciblor was administered, patient had the following side effects: international normalised ratio increased on Jan 03, 2006 from FRANCE Additional patient health information: Male patient , 76 years of age, . Ciblor dosage: 1g Twice Per Day. During the same period patient was treated with COUMADIN (2mg Per Day) (View Coumadin Review and Coumadin Label ), KETEK (400mg Twice Per Day) (View Ketek Review and Ketek Label ), CALCIPARINE (.2ml Twice Per Day) (View Calciparine Review and Calciparine Label ), TAVANIC (View Tavanic Review and Tavanic Label ). Patient was hospitalized.

4870702-1 | International Normalised Ratio Increased
Adverse event was reported on Dec 20, 2005 by a Male patient taking Ciblor (View Usage) (Dosage: 1g Twice Per Day) . Location: FRANCE , 75 years of age, Patient experienced the following unwanted or unexpected effects: international normalised ratio increased. During the same period patient was treated with COUMADIN (2mg Per Day) (View Coumadin Review and Coumadin Label ), KETEK (400mg Twice Per Day) (View Ketek Review and Ketek Label ), CALCIPARINE (.2ml Twice Per Day) (View Calciparine Review and Calciparine Label ), TAVANIC (View Tavanic Review and Tavanic Label ). Patient was hospitalized.

4864162-4 | International Normalised Ratio Increased
on Dec 20, 2005 Male patient from FRANCE , 75 years of age, was diagnosed with lung disorder and was treated with Ciblor (View Usage). Patient had the following side effects: international normalised ratio increased. Ciblor dosage: 1g Twice Per Day. During the same period patient was treated with COUMADIN (2mg Per Day) (View Coumadin Review and Coumadin Label ), KETEK (400mg Twice Per Day) (View Ketek Review and Ketek Label ), CALCIPARINE (.2ml Twice Per Day) (View Calciparine Review and Calciparine Label ), TAVANIC (View Tavanic Review and Tavanic Label ). Patient was hospitalized.

4861103-0 | Cheilitis, Enanthema, Oedema, Pruritus, Rash Erythematous, Rash Maculo-papular, Toxic Skin Eruption, Urticaria
on Dec 14, 2005 Female patient from FRANCE , 63 years of age, was treated with Ciblor (View Usage). After Ciblor was administered, patient had the following side effects: cheilitis, enanthema, oedema, pruritus, rash erythematous, rash maculo-papular, toxic skin eruption, urticaria. Ciblor dosage: 4ud Per Day. During the same period patient was treated with SOLU MEDROL (20mg Four Times Per Day) (View Solu-medrol Review and Solu-medrol Label ), TIAPROFENIC ACID (6ud Per Day) (View Tiaprofenic Acid Review and Tiaprofenic Acid Label ), NIFLURIL (View Nifluril Review and Nifluril Label ), NUROFEN (View Nurofen Review and Nurofen Label ), EFFERALGAN (500mg Twice Per Day) (View Efferalgan Review and Efferalgan Label ). Patient was hospitalized.

4761505-7 | Constipation, Extrapyramidal Disorder, Hypoprothrombinaemia, International Normalised Ratio Increased, Rectal Haemorrhage
Patient was taking Ciblor (View Usage). Patient experienced the following unwanted or unexpected effects: constipation (What is constipation?), extrapyramidal disorder, hypoprothrombinaemia, international normalised ratio increased, rectal haemorrhage on Aug 19, 2005 from FRANCE Additional patient health information: Male patient , 88 years of age, was diagnosed with bronchitis acute and. Ciblor dosage: 4tab Per Day. During the same period patient was treated with PREVISCAN (20mg Per Day) (View Previscan Review and Previscan Label ), BRONCHOKOD (3u Per Day) (View Bronchokod Review and Bronchokod Label ), MODOPAR (375mg Per Day) (View Modopar Review and Modopar Label ), NEXIUM (40mg Per Day) (View Nexium Review and Nexium Label ), DAFLON (View Daflon Review and Daflon Label ), FORLAX (2sac Per Day) (View Forlax Review and Forlax Label ), ANDROCUR (50mg Three Times Per Day) (View Androcur Review and Androcur Label ), STILNOX (1tab Per Day) (View Stilnox Review and Stilnox Label ). Patient was hospitalized.

4757685-X | Constipation, Extrapyramidal Disorder, Hypoprothrombinaemia, Rectal Haemorrhage
Adverse event was reported on Aug 19, 2005 by a Male patient taking Ciblor (View Usage) (Dosage: 4tab Per Day) was diagnosed with bronchitis (What is bronchitis?) and. Location: FRANCE , 88 years of age, Patient had the following side effects: constipation (What is constipation?), extrapyramidal disorder, hypoprothrombinaemia, rectal haemorrhage. During the same period patient was treated with PREVISCAN (20mg Per Day) (View Previscan Review and Previscan Label ), BRONCHOKOD (3u Per Day) (View Bronchokod Review and Bronchokod Label ), MODOPAR (1u Three Times Per Day) (View Modopar Review and Modopar Label ), NEXIUM (40mg Per Day) (View Nexium Review and Nexium Label ), DAFLON (View Daflon Review and Daflon Label ), FORLAX (View Forlax Review and Forlax Label ), ANDROCUR (50mg Three Times Per Day) (View Androcur Review and Androcur Label ), STILNOX (View Stilnox Review and Stilnox Label ). Patient was hospitalized.

4728772-7 | Diarrhoea, Gastrointestinal Candidiasis, Weight Decreased
on Jul 21, 2005 Female patient from FRANCE , 39 years of age, was diagnosed with asthma (What is asthma?) and was treated with Ciblor (View Usage). After Ciblor was administered, patient had the following side effects: diarrhoea, gastrointestinal candidiasis, weight decreased. Ciblor dosage: . During the same period patient was treated with ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), MEDROL (View Medrol Review and Medrol Label ), MUCOMYST (View Mucomyst Review and Mucomyst Label ), VENTOLIN (View Ventolin Review and Ventolin Label ). Patient was hospitalized.

4706493-4 | Angioneurotic Oedema, Bronchospasm, Urticaria
on Jun 23, 2005 Male patient from FRANCE , 53 years of age, was diagnosed with asthma (What is asthma?) and was treated with Ciblor (View Usage). Patient experienced the following unwanted or unexpected effects: angioneurotic oedema, bronchospasm, urticaria. Ciblor dosage: 1u Per Day. During the same period patient was treated with DOLIPRANE (View Doliprane Review and Doliprane Label ), PNEUMOREL (View Pneumorel Review and Pneumorel Label ), VENTOLIN (View Ventolin Review and Ventolin Label ), SERETIDE (View Seretide Review and Seretide Label ). Patient was hospitalized.

4706463-6 | Blood Bilirubin Increased, Chromaturia, Diarrhoea, Faeces Discoloured, Gamma-glutamyltransferase Increased, Jaundice Cholestatic, Pruritus
Patient was taking Ciblor (View Usage). Patient had the following side effects: blood bilirubin increased, chromaturia, diarrhoea, faeces discoloured, gamma-glutamyltransferase increased, jaundice cholestatic, pruritus on Jul 29, 2004 from FRANCE Additional patient health information: Male patient , 78 years of age, . Ciblor dosage: . Patient was hospitalized.

4690299-9 | Abdominal Pain, Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Bilirubin Increased, Blood Creatinine Increased, Cholelithiasis, Cholestasis, Gamma-glutamyltransferase Increased, Pyrexia
Adverse event was reported on May 30, 2005 by a Male patient taking Ciblor (View Usage) (Dosage: 1g Twice Per Day) was diagnosed with hyperthermia and. Location: , 86 years of age, After Ciblor was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), alanine aminotransferase increased, aspartate aminotransferase increased, blood bilirubin increased, blood creatinine increased, cholelithiasis, cholestasis, gamma-glutamyltransferase increased, pyrexia. During the same period patient was treated with ALDALIX (View Aldalix Review and Aldalix Label ), CORDARONE (View Cordarone Review and Cordarone Label ), CARDENSIEL (View Cardensiel Review and Cardensiel Label ), PREVISCAN (View Previscan Review and Previscan Label ), SERETIDE (View Seretide Review and Seretide Label ). Patient was hospitalized.

4684163-9 | Anaphylactic Shock, Blood Pressure Systolic Decreased, Chest Pain, Cough, Dysphonia, Pruritus, Sense Of Oppression, Swelling Face, Urticaria
on Sep 10, 2004 Female patient from , 36 years of age, was diagnosed with sinusitis (What is sinusitis?) and was treated with Ciblor (View Usage). Patient experienced the following unwanted or unexpected effects: anaphylactic shock, blood pressure systolic decreased, chest pain (What is chest pain?), cough, dysphonia, pruritus, sense of oppression, swelling face, urticaria. Ciblor dosage: 1000mg Per Day. During the same period patient was treated with FLUIMUCIL (View Fluimucil Review and Fluimucil Label ), TIAPROFENIC ACID (View Tiaprofenic Acid Review and Tiaprofenic Acid Label ), ADRENALINE (View Adrenaline Review and Adrenaline Label ).

4624182-1 | Blister, Conjunctivitis, Erythema, Lip Erosion, Mucosal Ulceration, Pain, Pyrexia, Stevens-johnson Syndrome, Tonsillitis
on Mar 22, 2005 Male patient from , 31 years of age, was diagnosed with tonsillitis and was treated with Ciblor (View Usage). Patient had the following side effects: blister, conjunctivitis, erythema, lip erosion, mucosal ulceration, pain (What is pain?), pyrexia, stevens-johnson syndrome, tonsillitis. Ciblor dosage: 2g Per Day. During the same period patient was treated with AOTAL (3tab Per Day) (View Aotal Review and Aotal Label ), TEGRETOL (200mg Per Day) (View Tegretol Review and Tegretol Label ), SURGAM (2tab Per Day) (View Surgam Review and Surgam Label ), RISPERDAL (1mg Per Day) (View Risperdal Review and Risperdal Label ). Patient was hospitalized.

4608852-7 | Dyspnoea, Hypersensitivity, Rales, Rash
Patient was taking Ciblor (View Usage). After Ciblor was administered, patient had the following side effects: dyspnoea, hypersensitivity, rales, rash (What is rash?) on Mar 08, 2005 from Additional patient health information: Female patient , 71 years of age, was diagnosed with bronchitis (What is bronchitis?), essential hypertension and. Ciblor dosage: 1tab Per Day. During the same period patient was treated with INDAPAMIDE (View Indapamide Review and Indapamide Label ), BISOPROLOL FUMARATE (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ). Patient was hospitalized.

4605976-5 | Dyspnoea, Hypersensitivity, Rales, Rash
Adverse event was reported on Feb 28, 2005 by a Female patient taking Ciblor (View Usage) (Dosage: 1tab Per Day) was diagnosed with bronchitis (What is bronchitis?) and. Location: , 71 years of age, Patient experienced the following unwanted or unexpected effects: dyspnoea, hypersensitivity, rales, rash (What is rash?). During the same period patient was treated with KETEK (View Ketek Review and Ketek Label ), FLUDEX (View Fludex Review and Fludex Label ), SOPROL (View Soprol Review and Soprol Label ), ALDACTONE (View Aldactone Review and Aldactone Label ). Patient was hospitalized.